Torley Helen's Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Sep 12, 2024
- Accession no.
- 0001415889-24-023307
- Filed
- Sep 12, 2024
- Trade date
- Sep 10-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.77M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torley HelenCIK 0001528185 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $13.87 | +$138,700 | 686,744 | Direct | |
| Sep 10, 2024 | Common Stock | SSaleDisposed | −10,000 | $59.09 | −$590,900 | 676,744 | Direct | |
| Sep 11, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $13.87 | +$138,700 | 686,744 | Direct | |
| Sep 11, 2024 | Common Stock | SSaleDisposed | −10,000 | $59.09 | −$590,900 | 676,744 | Direct | |
| Sep 12, 2024 | Common Stock | MOption exerciseAcquired | +10,000 | $13.87 | +$138,700 | 686,744 | Direct | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −10,000 | $59.20 | −$592,000 | 676,744 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $13.87 | −$138,700 | 70,000 | Direct | |
| Sep 11, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $13.87 | −$138,700 | 60,000 | Direct | |
| Sep 12, 2024 | Common Stock | MOption exerciseDisposed | −10,000 | $13.87 | −$138,700 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.